SLC5A2 and lobular neoplasia: Immunohistochemical analysis of renal biopsy specimens from both LN patients and MRL/lpr mice demonstrated increased SGLT2 expression co-localized with reduced synaptopodin levels, which were reversed by Empagliflozin treatment.